Safety and Efficacy of a Head Lice Shampoo
NCT06333054 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 109
Last updated 2024-03-27
Summary
This study is designed to compare the effectiveness and safety of test head lice shampoo (Test product) versus Goldgeist® Forte (reference product) following two applications.
Conditions
- Head Lice
Interventions
- DRUG
-
Pyrethrum Extract
Treatment with Goldgeist® Forte
- DEVICE
-
Silcap Shampoo
Treatment with Silcap Shampoo
Sponsors & Collaborators
-
Oystershell NV
lead INDUSTRY
Principal Investigators
-
Dörte Wolf, PhD · CardioSec Clinical Research GmbH
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 1 Year
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-10-13
- Primary Completion
- 2015-06-08
- Completion
- 2015-06-08
Countries
- Germany
Study Locations
More Related Trials
-
Phase 3 Study of OTO-104 in Subjects With Unilateral Meniere's Disease
NCT03664674 ·Status: COMPLETED ·Phase: PHASE3
-
Feasibility of Stereotactic Image Guidance on the Lateral Skull Base
NCT03852329 ·Status: TERMINATED ·Phase: NA
-
Bed Rest for Idiopathic Sudden Sensorineural Hearing Loss
NCT00416143 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Action of Intra-auricular Topical Lidocaine on Tinnitus
NCT05711641 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate SPI-1005 in Adults With Meniere's Disease
NCT02603081 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Investigation to Evaluate the Safety and Effectiveness of Cochlear Implantation in Children and Adults With Unilateral Hearing Loss/Single-sided Deafness
NCT05318417 ·Status: RECRUITING ·Phase: NA
-
The Influence of The Ear Popper on Serous Otitis Media and on the Accompanying Conductive Hearing Loss in Children
NCT00393159 ·Status: UNKNOWN ·Phase: PHASE4
-
OTO-313 in Subjects With Unilateral Subjective Tinnitus
NCT04829214 ·Status: COMPLETED ·Phase: PHASE2
-
A 1-Year Safety Study of OTO-104 in Subjects With Unilateral Meniere's Disease Located in United Kingdom
NCT02265393 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating Possible Improvement in Tinnitus Severity After 28 Days Dosing of the Study Drug AUT00063 Compared to Placebo
NCT02315508 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating Possible Improvement in Speech and Hearing Tests After 28 Days of Dosing of the Study Drug AUT00063 Compared to Placebo (QuicKfire)
NCT02832128 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Isosorbide Oral Solution in Patients With Meniere's Disease
NCT06765993 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
Otoprotection With SPI-1005 for Prevention of Temporary Auditory Threshold Shift
NCT01444846 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of STR001-IT and STR001-ER in Patients With SSHL
NCT03331627 ·Status: COMPLETED ·Phase: PHASE3
-
SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing Loss
NCT01451853 ·Status: WITHDRAWN ·Phase: PHASE2
-
Cochlear Implants in Young Children With SSD
NCT05775367 ·Status: RECRUITING ·Phase: NA
-
Comparison of Single Versus Repeat Doses of AM-101 in the Treatment of Acute Inner Ear Tinnitus
NCT01270282 ·Status: COMPLETED ·Phase: PHASE2
-
Isobide Solution and Meniace Tablets Compared to Monotherapy With Meniace Tablets
NCT02718846 ·Status: COMPLETED ·Phase: PHASE4
-
OTO-313 in Subjects With Subjective Tinnitus
NCT03918109 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy of AM 101 in Patients With Acute Inner Ear Tinnitus
NCT00860808 ·Status: COMPLETED ·Phase: PHASE2
-
The Effecttiveness of Intratympanic Methylprednisolon Injections Compared to Placebo in the Treatment of Vertigo Attacks in Meniere's Disease
NCT05851508 ·Status: RECRUITING ·Phase: PHASE3
-
Study of OTO-104 in Subjects With Unilateral Meniere's Disease
NCT02612337 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Patient's Position After Intra-tympanic Injection
NCT04384640 ·Status: UNKNOWN
-
Study of OTO-104 in Subjects With Unilateral Meniere's Disease
NCT02717442 ·Status: TERMINATED ·Phase: PHASE3
-
Sudden Deafness Treatment Trial
NCT00097448 ·Status: COMPLETED ·Phase: PHASE3